Published Date: 02 Mar 2023
Members of Congress are scrambling to test whether Bayh-Dole's "walk-in" provisions for patents on federally-funded discoveries could lower the cost of certain drugs in the United States.
Read Full NewsIn children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.
A population-based study finds that children with spina bifida are more likely than their peers in the general population to develop chronic kidney disease and ESRD — and to do so at younger ages.
1.
CAR T Cells Produce 10-Year Remissions in Some With Lymphoma
2.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.
3.
According to research, hospitals can save money and help cancer patients by implementing a basic intervention.
4.
Black and Hispanic children with high-risk neuroblastoma have worse outcomes despite standardized treatment
5.
Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma
1.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
2.
Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes
3.
Building Physical Resilience in Chronic Blood Disorders
4.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
5.
Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part IV
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation